Monitor the November 19 meeting for the vote outcome and the final reverse split ratio. If approved, the board's choice of ratio (1-for-30 would reduce shares from ~95M to ~3.2M, potentially boosting per-share price but signaling severe distress. Watch for further activist sales or a potential equity offering post-split.
Price Chart
Executive Summary
MDxHealth SA filed a 6-K convening an extraordinary general meeting on November 19, 2026, to seek shareholder approval for a reverse stock split (share consolidation) at a ratio between 1-for-5 and 1-for-30. The filing follows a recent SC 13D/A showing the activist Bleichroeder LP reduced its 32.04% stake through open-market sales, signaling potential distress. The reverse split aims to boost the stock price to maintain Nasdaq listing compliance, but the activist's selling and the company's $18M market cap raise concerns about shareholder approval and post-split viability.
Key Facts
- Extraordinary general meeting scheduled for November 19, 2026, to vote on a reverse stock split with a ratio ranging from 1-for-5 to 1-for-30.
- The board is authorized to determine the final ratio within six months of the meeting; if not implemented within that period, authority expires unless renewed.
- The reverse split will not change the company's share capital but will reduce the number of outstanding shares proportionally.
- A quorum of at least 50% of outstanding shares is required; if not met, a second meeting on December 10, 2026, will have no quorum requirement.
- The proposed resolution requires approval by 75% of votes validly cast.
- Activist Bleichroeder LP disclosed a 32.04% stake in a SC 13D/A filed October 15, 2026, and sold approximately 1.1 million shares between September 17 and October 13, 2026, at prices from $0.5104 to $0.6733 per share.
- Market cap is $18M with a normal daily move of 11.1%, indicating high volatility.
- No periodic financial results are included in this filing; it is a governance/meeting notice only.
Financial Impact
No financial figures provided in the filing; the reverse split does not change market cap or capital. The activist's recent sales of ~1.1M shares at $0.51-$0.67/share suggest a total value of approximately $0.6M-$0.7M.
Risk Factors
- The reverse split may fail to achieve Nasdaq compliance if the stock price remains low or if the 75% supermajority vote is not obtained.
- Activist Bleichroeder LP's recent selling suggests reduced confidence in the company's near-term prospects.
- No financial results or guidance are provided; the filing contains no operational update.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-114400 |
| Document: ea031016501ex99-1.htm | 0001213900-26-114400 |
| Document: ea031016501ex99-3.htm | 0001213900-26-114400 |
| Document: ea031016501ex99-2.htm | 0001213900-26-114400 |
| Document: ea0310165-6k_mdxhealth.htm | 0001213900-26-114400 |
| Document: 0001213900-26-114400-index-headers.html | 0001213900-26-114400 |
| Document: 0001213900-26-114400-index.html | 0001213900-26-114400 |
| Document: 0001213900-26-114400.txt | 0001213900-26-114400 |
| Earnings Context (Synthetic; results releases only) | 0001213900-26-114400 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | 6-K | $0.1802 | awaiting T+20 | awaiting T+20 | $0.1630 (+9.54%) |
Oct 16, 2026 16d ago | 6-K | No price | awaiting T+20 | awaiting T+20 | No price |
Oct 15, 2026 17d ago | SC 13D/A | $0.2066 | awaiting T+20 | awaiting T+20 | $0.1630 (+21.10%) |
Oct 15, 2026 17d ago | Press Release | $0.2066 | awaiting T+20 | awaiting T+20 | $0.1630 (+21.10%) |
Sep 17, 2026 6w ago | 144 | $0.6300 $0.2070 | ▲ +67.14% | ▲ +67.35% | $0.1630 (+74.13%) |
Sep 3, 2026 8w ago | 6-K | $0.7484 $0.5969 | ▲ +20.24% | ▲ +20.85% | $0.1630 (+78.22%) |
Aug 13, 2026 11w ago | 6-K | $0.8080 $0.7072 | ▲ +12.48% | ▲ +10.48% | $0.1630 (+79.83%) |
Aug 13, 2026 11w ago | Press Release | $0.8080 $0.7072 | ▼ −12.48% | ▼ −10.48% | $0.1630 (−79.83%) |
Jul 24, 2026 14w ago | 6-K | $0.4180 $0.7413 | ▼ −77.34% | ▼ −74.05% | $0.1630 (+61.00%) |
Jul 2, 2026 17w ago | Press Release | $0.4765 $0.4077 | ▲ +14.44% | ▲ +14.02% | $0.1630 (+65.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers